Louis E. Schroder
Impact in
-
- Radiopharmaceutical Chemistry and Applications
- Medical Imaging Techniques and Applications
- Boron Compounds in Chemistry
-
- Bone health and treatments
- Cancer Diagnosis and Treatment
Papers in
- Oncology 9
- Bone health and treatments 4
- Drug Transport and Resistance Mechanisms 2
-
- Medical Imaging and Pathology Studies 4
- Vasculitis and related conditions 1
- Co-authors
- Harry R. Maxon (5 shared papers)Jonathan S. Moulton (4 shared papers)Craig C. Williams (4 shared papers)R. C. Samaratunga (3 shared papers)Vicki Hertzberg (3 shared papers)Gary J. Ehrhardt (3 shared papers)Stephen Thomas (3 shared papers)Emanuela Englaro (3 shared papers)
- Journals
- Urologic Oncology Seminars and Original Investigations (2 papers)Investigational New Drugs (1 paper)Archives of Pathology & Laboratory Medicine (1 paper)Cancer Chemotherapy and Pharmacology (1 paper)Radiology (1 paper)
- Partner nations
- United States
In The Last Decade
Louis E. Schroder
16 papers receiving 447 citations
Peers
Comparison fields: 5 of 57
- Radiology, Nuclear Medicine and Imaging 286
- Oncology 195
- Pulmonary and Respiratory Medicine 162
- Radiation 27
- Surgery 109
Countries citing papers authored by Louis E. Schroder
This map shows the geographic impact of Louis E. Schroder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Louis E. Schroder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Louis E. Schroder more than expected).
Fields of papers citing papers by Louis E. Schroder
This network shows the impact of papers produced by Louis E. Schroder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Louis E. Schroder. The network helps show where Louis E. Schroder may publish in the future.
Co-authors
The 25 scholars most cited alongside Louis E. Schroder, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Rhenium-186(Sn)HEDP for treatment of painful osseous metastases: results of a double-blind crossover comparison with placebo. | 1991 | 127 |
| 2 | 1990 | 114 | |
| 3 | Rhenium-188(Sn)HEDP for treatment of osseous metastases. | 1998 | 71 |
| 4 | 1992 | 62 | |
| 5 | 1992 | 19 | |
| 6 | 1999 | 15 | |
| 7 | 2000 | 15 | |
| 8 | 1997 | 11 | |
| 9 | 1986 | 8 | |
| 10 | 2001 | 7 | |
| 11 | 1991 | 7 | |
| 12 | 1983 | 3 | |
| 13 | 2001 | 2 | |
| 14 | 1990 | 2 | |
| 15 | [Clinical classification of the severity of lung injuries (author's transl)]. | 1979 | 2 |
| 16 | 1997 | 1 |
About Louis E. Schroder
Louis E. Schroder is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging, Surgery and Molecular Biology, having authored 16 papers that have together received 466 indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (5 papers), Bone health and treatments (4 papers), Medical Imaging and Pathology Studies (4 papers), Drug Transport and Resistance Mechanisms (2 papers), Coffee research and impacts (1 paper), Vasculitis and related conditions (1 paper), Bartonella species infections research (1 paper) and Gout, Hyperuricemia, Uric Acid (1 paper). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (286 citations), Oncology (195 citations), Pulmonary and Respiratory Medicine (162 citations), Radiation (27 citations) and Surgery (109 citations). Louis E. Schroder has collaborated with scholars based in United States. Frequent co-authors include Harry R. Maxon, Jonathan S. Moulton, Craig C. Williams, R. C. Samaratunga, Vicki Hertzberg, Gary J. Ehrhardt, Stephen Thomas, Emanuela Englaro, Howard I. Scher and Herbert J. Smith. Their work appears in journals such as Urologic Oncology Seminars and Original Investigations, Investigational New Drugs, Archives of Pathology & Laboratory Medicine, Cancer Chemotherapy and Pharmacology and Radiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.